SBC / revenue moved 247 bp higher
SBC / revenue changed +247 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue changed +247 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +1305 basis points from the comparable as-filed period.
Capital expenditure changed +158.1% from the comparable as-filed period.
Receivables / revenue changed -2094 basis points from the comparable as-filed period.
Working capital / assets changed -3471 basis points from the comparable as-filed period.
Free-cash-flow margin changed -570 basis points from the comparable as-filed period.
Operating cash-flow margin changed -545 basis points from the comparable as-filed period.
Operating cash flow / net income changed -18.4% from the comparable as-filed period.
Capex / revenue changed +26 basis points from the comparable as-filed period.
R&D / revenue changed +40 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -0.2% from the comparable as-filed period.
Stock-based compensation changed +222.2% from the comparable as-filed period.
Selling, general & administrative changed +116.3% from the comparable as-filed period.
SBC / revenue changed +82 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.